Investors’ IP Rights Unbound: The Danger of Investment Clauses to Access to Medicines

[Cross posted from Equilibri.net] Although access to medicines activists have been wise to focus our attention intently on convincing low- and middle-income countries to adopt and use all possible TRIPS-compliant flexibilities and to oppose the TRIPS-plus IP chapters in free trade agreements, we have neglected to interrogate another chapter in free trade agreements and bilateral [...]